BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34267020)

  • 1. [Preparation of the Cancer Genomic Medicine in the Tohoku District-Activity of Tohoku University Hospital as the Cancer Genome Medicine Core Base Hospital in Japan].
    Ishioka C
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):878-881. PubMed ID: 34267020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cooperative Tasks among Cancer Genome Medicine Facilities].
    Shirota H
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):997-999. PubMed ID: 36156024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and implementation of Cancer Genomic Medicine in Japan.
    Mukai Y; Ueno H
    Cancer Sci; 2021 Mar; 112(3):970-977. PubMed ID: 33289217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Role of Core Hospital of Cancer Genomic Medicine and Regional Cooperation].
    Shirota H; Komine K
    Gan To Kagaku Ryoho; 2020 Aug; 47(8):1149-1152. PubMed ID: 32829345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The Tohoku Next-Generation Cancer Professional Training Plan-Results, Problems and the Future Prospects].
    Ishioka C
    Gan To Kagaku Ryoho; 2022 May; 49(5):516-519. PubMed ID: 35578924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of Cancer Genomic Medicine in Kyushu Region and the Roles of Kyushu University Hospital as a Core Hospital for Cancer Genomic Medicine].
    Ito M; Baba E
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):873-877. PubMed ID: 34267019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer genomic medicine in Japan.
    Mano H
    Proc Jpn Acad Ser B Phys Biol Sci; 2020; 96(7):316-321. PubMed ID: 32788553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan.
    Kohno T; Kato M; Kohsaka S; Sudo T; Tamai I; Shiraishi Y; Okuma Y; Ogasawara D; Suzuki T; Yoshida T; Mano H
    Cancer Discov; 2022 Nov; 12(11):2509-2515. PubMed ID: 36321305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Panel Discussion - Problems in the Cancer Genomic Medicine].
    Ishioka C; Muto M; Yachida S; Shirota H; Hirasawa A; Miyagawa K; Ashizawa K; Kinoshita I; Nishihara H; Matsuura N; Sakurai A
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1014-1017. PubMed ID: 36156030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current Status and Future Direction of Cancer Genomic Medicine in Japan].
    Muto M
    Gan To Kagaku Ryoho; 2020 Feb; 47(2):197-202. PubMed ID: 32381946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From the Standpoint of a Core Center Hospital for Cancer Genome Medicine-Establishment of a Provision System for Wide-Area Precision Oncology].
    Muto M; Kondo T; Yoshioka M; Fukuyama K; Suga J; Sato M; Masuda F; Ashida K; Mukai K; Matsumoto S; Kanai M
    Gan To Kagaku Ryoho; 2021 Jul; 48(7):866-872. PubMed ID: 34267018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Role of Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
    Sunami K
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):617-621. PubMed ID: 31164495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer genomic medicine in Japan and the roles of pharmacists.
    Aomori T; Sakurai H; Nishihara H
    Pharmacogenet Genomics; 2022 Aug; 32(6):242-245. PubMed ID: 35696282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Data-Sharing Systems of the Center for Cancer Genomics and Advanced Therapeutics(C-CAT)Repository Database and Expectation for the Future Medical Research and Development].
    Suzuki T
    Gan To Kagaku Ryoho; 2022 Nov; 49(11):1175-1182. PubMed ID: 36412016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Issues of Equalization of Cancer Genomic Medicine-Focusing on the Current Status in Nagasaki Prefecture].
    Ashizawa K; Udo E; Soda M; Furusato B
    Gan To Kagaku Ryoho; 2022 Sep; 49(9):1005-1007. PubMed ID: 36156027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interinstitutional Collaboration for Molecular Tumor Boards].
    Komine K; Shirota H
    Gan To Kagaku Ryoho; 2019 Apr; 46(4):626-629. PubMed ID: 31164497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan.
    Yoshida T; Yatabe Y; Kato K; Ishii G; Hamada A; Mano H; Sunami K; Yamamoto N; Kohno T
    Cancer Biol Med; 2023 May; 21(1):29-44. PubMed ID: 37133223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Roles of Designated Core Hospitals and Cooperative Hospitals for Cancer Genomic Medicine in Japan].
    Nishida T
    Gan To Kagaku Ryoho; 2018 Sep; 45(9):1223-1227. PubMed ID: 30237359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [One year after the Great Tohoku Disaster].
    Aoki M
    Rinsho Shinkeigaku; 2012; 52(11):1336-8. PubMed ID: 23196610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.